Anemia, Iron-Deficiency  >>  Monofer (iron isomaltoside 1000)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Monofer (iron isomaltoside 1000) / Pharmacosmos
NCT01469078: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D)

Completed
1
18
US
Monofer®
Pharmacosmos A/S, ClinSmart
Chronic Kidney Disease
04/12
11/12
NCT03013439: Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

Completed
1
24
Japan
Iron Isomaltoside, Monofer
Pharmacosmos A/S
Anemia, Deficiency Diseases, Anemia, Iron Deficiency, Hematologic Disease, Iron Metabolism Disorders
06/17
06/17

Download Options